Effective method for the heat inactivation of Blastomyces dermatitidis
Authors:
- E. M. BrownEBE. M. Brown
- L. R. McTaggartLML. R. McTaggart
- D. E. LowDLD. E. Low
- 21 July 2014
- journal article
- Published by Oxford University Press (OUP) in Medical Mycology
- Vol. 52 (7) , 766-769
Abstract
Manipulation of Blastomyces dermatitidis requires the use of containment level 3 (CL3) practices. However, access to CL3 laboratories is limited and working conditions are restrictive. We describe the validation of a "heat-killing" method to inactivate B. dermatitidis, thus allowing cellular material to be removed from the CL3 laboratory for subsequent DNA isolation that is suitable for genetic applications.Keywords
This publication has 5 references indexed in Scilit:
- Phylogenetic Analysis Reveals a Cryptic Species Blastomyces gilchristii, sp. nov. within the Human Pathogenic Fungus Blastomyces dermatitidisPLOS ONE, 2013
- Role of Glucan and Surface Protein BAD1 in Complement Activation byBlastomyces dermatitidisYeastInfection and Immunity, 2001
- The WI-1 antigen of Blastomyces dermatitidis yeasts mediates binding to human macrophage CD11b/CD18 (CR3) and CD14.The Journal of Immunology, 1995
- Conversion of Blastomyces dermatitidis to the yeast form at 37 degrees C and 26 degrees CJournal of Clinical Microbiology, 1984
- Primary Pulmonary Blastomycosis: A Laboratory-Acquired InfectionAnnals of Internal Medicine, 1970